PCN Insights, News, Videos, and More

Stem cell-derived neurons from combat veterans reacted differently to a stress hormone depending on whether the individual had PTSD, according to findings published in Nature Neuroscience.

Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.

NeuroSigma Inc. recently announced the commercial launch of a bioelectronic medical device that uses external trigeminal nerve stimulation (eTNS) to treat children with ADHD.

Ketamine was found to be an effective treatment for patients with treatment-resistant depression.

Adults with MDD showed increased brain connectivity after about 6 weeks of inpatient depression treatment.

The Veterans Health Administration program lowered risk of suicide in veterans with psychiatric disorders.

The more hours a first-year medical resident worked in a week, the higher their chances of developing depressive symptoms rose, according to study results published in the New England Journal of Medicine.

More than a third of Americans who have seen a therapist within the past 30 days said they feel positively about psychedelics being used as part of mental health treatment, and nearly half would support legalization of at least some...

Donanemab treatment lowered plasma biomarkers phosphorylated tau217 and glial fibrillary acidic protein compared with placebo in patients with early symptomatic Alzheimer disease, according to a study published in JAMA Neurology.

Extended-release dextromethorphan HBr-bupropion HCl (Auvelity™) approved for the treatment of MDD.